Critical Updates in the Treatment of HIV and STIs

This activity will discuss updates in HIV therapy, particularly two-drug regimens. The faculty will also review STI treatment guideline updates.

Cystic Fibrosis #1: An Overview

Module 1 will provide an overview of CF disease. The metabolism differences to consider in CF patients will also be addressed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #2: Chronic Medications: Changing the Course of Cystic Fibrosis

Module 2 reviews the chronic medications used in CF patients. It will also discuss some of the future directions being explored with medications for CF. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #3: Management of Acute Pulmonary Exacerbations: Pseudomonas and Beyond

Module 3 addresses the management of infections in CF patients and the use of antibiotics in CF patients. It will review the PK and PD considerations to in these patients. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #4: Adherence, Access, Education: Current Challenges and Overcoming Barriers in CF Medications

Module 4 discusses the importance of adherence in CF patients and will address the role of education to improve the treatment of CF patients. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Desensitization to Antibiotic Allergies

This activity will use five clinical scenarios to explore treatment options for patients with antibiotic allergies. SIDP Members visit www.SIDP.org/MbrRate for member pricing.

Dismantling Structural Racism in Pharmacy: Why it Matters to Our Underrepresented Minority Community

This activity will provide key definitions as a basis for discussion of systemic and structural racism in communities and the pharmacy profession. A case study will be used to highlight aspects of this topic and ways to improve the health of the community through diversity, equity and inclusion.

Early Antifungals in the ICU: Untangling the Unnecessarily Complex

This activity will focus on antifungals and discuss evidence regarding their use on invasive candidiasis in critically ill patients. Non-culture diagnostic techniques will also be evaluated.

Emerging Insights on the Role of Monoclonal Antibodies in Patients with COVID-19

This activity will improve the knowledge and competency of pharmacists and nurses about the stages of COVID-19 and the role disease progression plays in therapeutic options, the safety and efficacy data, and best practices for monoclonal antibodies for use in COVID-19.

Enzyme Replacement Therapies

Three LSDs will be discussed (Gaucher, Anderson-Fabry and Pompe). For each disease, biomarkers, symptoms, complications and other therapeutic options besides ERTs will be addressed. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.